GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Interpharm Holdings Inc (GREY:IPAH) » Definitions » EV-to-FCF

Interpharm Holdings (Interpharm Holdings) EV-to-FCF : 0.00 (As of Jun. 22, 2024)


View and export this data going back to 2008. Start your Free Trial

What is Interpharm Holdings EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Interpharm Holdings's Enterprise Value is $0.00 Mil. Interpharm Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2007 was $-29.61 Mil. Therefore, Interpharm Holdings's EV-to-FCF for today is 0.00.

The historical rank and industry rank for Interpharm Holdings's EV-to-FCF or its related term are showing as below:

IPAH's EV-to-FCF is not ranked *
in the Drug Manufacturers industry.
Industry Median: 22.83
* Ranked among companies with meaningful EV-to-FCF only.

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-22), Interpharm Holdings's stock price is $0.0001. Interpharm Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2007 was $-0.510. Therefore, Interpharm Holdings's PE Ratio for today is At Loss.


Interpharm Holdings EV-to-FCF Historical Data

The historical data trend for Interpharm Holdings's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Interpharm Holdings EV-to-FCF Chart

Interpharm Holdings Annual Data
Trend Jun98 Jun99 Jun00 Jun01 Jun02 Jun03 Jun04 Jun05 Jun06 Jun07
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - -33.96 -4.70 -9.74 -5.04

Interpharm Holdings Quarterly Data
Mar03 Jun03 Sep03 Dec03 Mar04 Jun04 Sep04 Dec04 Mar05 Jun05 Sep05 Dec05 Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Interpharm Holdings's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Interpharm Holdings's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Interpharm Holdings's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Interpharm Holdings's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Interpharm Holdings's EV-to-FCF falls into.



Interpharm Holdings EV-to-FCF Calculation

Interpharm Holdings's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=0.000/-29.606
=0.00

Interpharm Holdings's current Enterprise Value is $0.00 Mil.
Interpharm Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2007 adds up the quarterly data reported by the company within the most recent 12 months, which was $-29.61 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Interpharm Holdings  (GREY:IPAH) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Interpharm Holdings's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.0001/-0.510
=At Loss

Interpharm Holdings's share price for today is $0.0001.
Interpharm Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2007 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.510.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Interpharm Holdings EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Interpharm Holdings's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Interpharm Holdings (Interpharm Holdings) Business Description

Traded in Other Exchanges
N/A
Address
75 Adams Avenue, Hauppague, NY, USA, 11788
Website
Interpharm Holdings Inc manufactures generic and over-the-counter medications. The company also pursues the development of other generic drugs in broad categories.

Interpharm Holdings (Interpharm Holdings) Headlines

No Headlines